MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PRME made $856K in revenue. -$49,122K in net income. Net profit margin of -5738.55%.

Income Overview

Revenue
$856K
Net Income
-$49,122K
Net Profit Margin
-5738.55%
EPS
-$0.28
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Collaboration revenue
856 838 1,225 1,115
Research and development
34,105 34,709 43,990 41,375
General and administrative
17,405 14,737 11,208 13,117
Total operating expenses
51,510 49,446 55,198 54,492
Loss from operations
-50,654 -48,608 -53,973 -53,377
Interest income
1,021 1,083 1,141 743
Accretion (amortization) of investments
460 858 752 530
Change in fair value of short-term investment related party
0 539 1,454 -505
Other income, net
51 49 44 18
Total other income, net
1,532 2,529 3,391 786
Net loss before income taxes
----52,591
Provision for income taxes
---0
Net loss attributable to common stockholders, basic
-49,122 -46,079 -50,582 -52,591
Net loss attributable to common stockholders, diluted
-49,122 --50,582 -52,591
Basic EPS
-0.28 -0.264 -0.32 -0.41
Diluted EPS
-0.28 -0.264 -0.32 -0.41
Basic Average Shares
177,096,225 174,460,517 160,503,183 129,185,918
Diluted Average Shares
177,096,225 174,460,517 160,503,183 129,185,918
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$49,122K (5.33%↑ Y/Y)Interest income$1,021K (-13.62%↓ Y/Y)Accretion (amortization)of investments$460K (35.69%↑ Y/Y)Other income, net$51K (37.84%↑ Y/Y)Net lossattributable to common...-$49,122K (5.33%↑ Y/Y)Total other income,net$1,532K (205.18%↑ Y/Y)Loss from operations-$50,654K (3.32%↑ Y/Y)Collaboration revenue$856K (-41.13%↓ Y/Y)Total operatingexpenses$51,510K (-4.34%↓ Y/Y)Research and development$34,105K (-15.92%↓ Y/Y)General andadministrative$17,405K (31.02%↑ Y/Y)

Prime Medicine, Inc. (PRME)

Prime Medicine, Inc. (PRME)